Hu B - Search Results

1

Membrane-destabilizing ionizable lipid empowered imaging-guided siRNA delivery and cancer treatment.

Guo S, Li K, Hu B, Li C, Zhang M, Hussain A, Wang X, Cheng Q, Yang F, Ge K, Zhang J, Chang J, Liang XJ, Weng Y, Huang Y. Guo S, et al. Among authors: hu b. Exploration (Beijing). 2021 Sep 1;1(1):35-49. doi: 10.1002/EXP.20210008. eCollection 2021 Aug. Exploration (Beijing). 2021. PMID: 37366466 Free PMC article.

2

siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin.

Zheng S, Wang X, Weng YH, Jin X, Ji JL, Guo L, Hu B, Liu N, Cheng Q, Zhang J, Bai H, Yang T, Xia XH, Zhang HY, Gao S, Huang Y. Zheng S, et al. Among authors: hu b. Mol Ther Nucleic Acids. 2018 Sep 7;12:805-816. doi: 10.1016/j.omtn.2018.08.003. Epub 2018 Aug 8. Mol Ther Nucleic Acids. 2018. PMID: 30153565 Free PMC article.

3

Fluorinated Oligoethylenimine Nanoassemblies for Efficient siRNA-Mediated Gene Silencing in Serum-Containing Media by Effective Endosomal Escape.

Zhang T, Huang Y, Ma X, Gong N, Liu X, Liu L, Ye X, Hu B, Li C, Tian JH, Magrini A, Zhang J, Guo W, Xing JF, Bottini M, Liang XJ. Zhang T, et al. Among authors: hu b. Nano Lett. 2018 Oct 10;18(10):6301-6311. doi: 10.1021/acs.nanolett.8b02553. Epub 2018 Sep 27. Nano Lett. 2018. PMID: 30240228

4

Clinical advances of siRNA therapeutics.

Hu B, Weng Y, Xia XH, Liang XJ, Huang Y. Hu B, et al. J Gene Med. 2019 Jul;21(7):e3097. doi: 10.1002/jgm.3097. Epub 2019 Jun 17. J Gene Med. 2019. PMID: 31069898 Review.

5

The challenge and prospect of mRNA therapeutics landscape.

Weng Y, Li C, Yang T, Hu B, Zhang M, Guo S, Xiao H, Liang XJ, Huang Y. Weng Y, et al. Among authors: hu b. Biotechnol Adv. 2020 May-Jun;40:107534. doi: 10.1016/j.biotechadv.2020.107534. Epub 2020 Feb 21. Biotechnol Adv. 2020. PMID: 32088327 Review.

6

Therapeutic siRNA: state of the art.

Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, Liang XJ. Hu B, et al. Signal Transduct Target Ther. 2020 Jun 19;5(1):101. doi: 10.1038/s41392-020-0207-x. Signal Transduct Target Ther. 2020. PMID: 32561705 Free PMC article. Review.

7

ROS-Activatable siRNA-Engineered Polyplex for NIR-Triggered Synergistic Cancer Treatment.

Zhang M, Weng Y, Cao Z, Guo S, Hu B, Lu M, Guo W, Yang T, Li C, Yang X, Huang Y. Zhang M, et al. Among authors: hu b. ACS Appl Mater Interfaces. 2020 Jul 22;12(29):32289-32300. doi: 10.1021/acsami.0c06614. Epub 2020 Jul 9. ACS Appl Mater Interfaces. 2020. PMID: 32584027

8

Harnessing pH-Sensitive Polycation Vehicles for the Efficient siRNA Delivery.

Wang C, Wang X, Du L, Dong Y, Hu B, Zhou J, Shi Y, Bai S, Huang Y, Cao H, Liang Z, Dong A. Wang C, et al. Among authors: hu b. ACS Appl Mater Interfaces. 2021 Jan 20;13(2):2218-2229. doi: 10.1021/acsami.0c17866. Epub 2021 Jan 6. ACS Appl Mater Interfaces. 2021. PMID: 33406826

9

siRNA Design and GalNAc-Empowered Hepatic Targeted Delivery.

Lu M, Zhang M, Hu B, Huang Y. Lu M, et al. Among authors: hu b. Methods Mol Biol. 2021;2282:77-100. doi: 10.1007/978-1-0716-1298-9_6. Methods Mol Biol. 2021. PMID: 33928571

10

Ionizable lipid-assisted efficient hepatic delivery of gene editing elements for oncotherapy.

Li C, Yang T, Weng Y, Zhang M, Zhao D, Guo S, Hu B, Shao W, Wang X, Hussain A, Liang XJ, Huang Y. Li C, et al. Among authors: hu b. Bioact Mater. 2021 Jun 25;9:590-601. doi: 10.1016/j.bioactmat.2021.05.051. eCollection 2022 Mar. Bioact Mater. 2021. PMID: 34853819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,761 results

Search Page